{
    "2021-06-16": [
        [
            {
                "time": "",
                "original_text": "上海医药(02607.HK)：瑞舒伐他汀钙片获得批准生产",
                "features": {
                    "keywords": [
                        "上海医药",
                        "瑞舒伐他汀钙片",
                        "批准生产"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药(601607.SH)：瑞舒伐他汀钙片获得批准生产",
                "features": {
                    "keywords": [
                        "上海医药",
                        "瑞舒伐他汀钙片",
                        "批准生产"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药：A股定增方案获上实集团批复",
                "features": {
                    "keywords": [
                        "上海医药",
                        "A股定增",
                        "上实集团",
                        "批复"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药(601607.SH)：A股定增方案获上实集团批复",
                "features": {
                    "keywords": [
                        "上海医药",
                        "A股定增",
                        "上实集团",
                        "批复"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}